Resonant Medical, an innovator in 3D soft tissue planning, image-guidance and adaptive radiotherapy products, headquartered in Montreal, Canada, today announced that the Company is exhibiting the next generation of software for its Clarity System at the 51st annual American Society of Radiation Oncology (ASTRO) Annual Meeting taking place November 1-5, 2009 in Chicago.
Resonant Medical will also be hosting a special cocktail session on November 2nd with the theme of “Breast Conservation Therapy: Present and Future.” The event will include a panel discussion with three leading experts in the area of breast conservation therapy: Dr. Alphonse Taghian, PhD. of Massachusetts General Hospital, Dr. Ruth Heimann, PhD. of University of Vermont Cancer Center and Dr. Martin Keisch of the University of Miami Hospital. Panelists will discuss breast conservation therapy options, including current methodologies and future treatment trends.
In addition, Resonant is proud to note that four medical institutions currently using the Clarity System will be presenting abstracts at this year’s ASTRO. The abstracts describe evaluations of:
- The use of Clarity in breast IGRT; (Two abstracts; University of Vermont in Burlington & McGill University in Montreal, Canada)
- The use of several IGRT methods on prostate patients, including Clarity, cone beam CT and implanted markers; (Henry Ford Health System in Detroit, Michigan)
- The use of Clarity to provide planning and IGRT for prostate patients with hip prostheses. (Concord Hospital, Payson Center for Cancer Care, New Hampshire)
The Clarity System is a radiation-free, non-invasive gentle approach to imaging soft tissue that provides the benefits of automatic hybrid imaging during planning, anatomy-based daily treatment guidance and adaptive radiotherapy. The Clarity System allows physicians to visualize the soft tissue target anatomy during each step of the patient flow from planning through treatment. During planning, the Clarity System offers a cost effective soft tissue hybrid imaging solution in the CT suite, allowing CT and 3D ultrasound images to be acquired at the same time with the patient in the same position. These hybrid images are automatically fused and made available to the physician for enhanced target definition. During treatment, Clarity image-guided radiation therapy (IGRT) uses rapid daily auto-segmentation of anatomy to visualize and adjust to daily 3D structural changes, thus ensuring precise and accurate daily delivery of radiation to the intended target and sparing of healthy surrounding tissue.